INE0CZ201020
INE0CZ201020
ANTHEM BIOSCIENCES LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 484.37B EUR | 433.9B EUR | 368.62B EUR | 366.49B EUR |
Enterprise Value | 475.52B EUR | 433.9B EUR | 366.43B EUR | 366.49B EUR |
Valuation Multiples | ||||
Trailing P/E | 84.96x | 75.34x | 62.29x | 91.16x |
Forward P/E | 57.05x | -- | -- | -- |
Price to Sales | 24.13x | 21.67x | 17.35x | 24.22x |
Price to Book | 15.92x | -- | 12.12x | -- |
EV/Revenue | 23.69x | 21.67x | 17.25x | 24.22x |
EV/EBITDA | 58.94x | 45.64x | 37.03x | 54.6x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |